187 related articles for article (PubMed ID: 23278106)
1. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.
Hubmann R; Hilgarth M; Schnabl S; Ponath E; Reiter M; Demirtas D; Sieghart W; Valent P; Zielinski C; Jäger U; Shehata M
Br J Haematol; 2013 Mar; 160(5):618-29. PubMed ID: 23278106
[TBL] [Abstract][Full Text] [Related]
2. Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL.
Hubmann R; Schnabl S; Araghi M; Schmidl C; Rendeiro AF; Hilgarth M; Demirtas D; Ali F; Staber PB; Valent P; Zielinski C; Jäger U; Shehata M
Cells; 2020 Jun; 9(6):. PubMed ID: 32570839
[TBL] [Abstract][Full Text] [Related]
3. NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
Hubmann R; Düchler M; Schnabl S; Hilgarth M; Demirtas D; Mitteregger D; Hölbl A; Vanura K; Le T; Look T; Schwarzmeier JD; Valent P; Jäger U; Shehata M
Br J Haematol; 2010 Mar; 148(6):868-78. PubMed ID: 19995395
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.
Duechler M; Shehata M; Schwarzmeier JD; Hoelbl A; Hilgarth M; Hubmann R
Leukemia; 2005 Feb; 19(2):260-7. PubMed ID: 15565166
[TBL] [Abstract][Full Text] [Related]
5. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response.
Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D
Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742
[TBL] [Abstract][Full Text] [Related]
7. Expression of ZAP70 in chronic lymphocytic leukaemia activates NF-κB signalling.
Pede V; Rombout A; Vermeire J; Naessens E; Vanderstraeten H; Philippé J; Verhasselt B
Br J Haematol; 2013 Dec; 163(5):621-30. PubMed ID: 24219331
[TBL] [Abstract][Full Text] [Related]
8. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
Rosati E; Sabatini R; Rampino G; Tabilio A; Di Ianni M; Fettucciari K; Bartoli A; Coaccioli S; Screpanti I; Marconi P
Blood; 2009 Jan; 113(4):856-65. PubMed ID: 18796623
[TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells.
Ringshausen I; Dechow T; Schneller F; Weick K; Oelsner M; Peschel C; Decker T
Leukemia; 2004 Dec; 18(12):1964-70. PubMed ID: 15483673
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Notch Gene and Its Role of Anti-apoptosis and Drug-resistance of Cells in Chronic Lymphocytic Leukemia].
Zhang JY; Zhang JS; Xu ZS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):919-24. PubMed ID: 26314418
[TBL] [Abstract][Full Text] [Related]
11. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib induces different apoptotic rates in B-CLL cells according to IgVH and BCL-6 mutations.
Jantus-Lewintre E; Sarsotti E; Terol MJ; Benet I; García-Conde J
Clin Transl Oncol; 2006 Nov; 8(11):805-11. PubMed ID: 17134969
[TBL] [Abstract][Full Text] [Related]
14. Microenvironmental stromal cells abrogate NF-κB inhibitor-induced apoptosis in chronic lymphocytic leukemia.
Simon-Gabriel CP; Foerster K; Saleem S; Bleckmann D; Benkisser-Petersen M; Thornton N; Umezawa K; Decker S; Burger M; Veelken H; Claus R; Dierks C; Duyster J; Zirlik K
Haematologica; 2018 Jan; 103(1):136-147. PubMed ID: 29122993
[TBL] [Abstract][Full Text] [Related]
15. Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines
Hubmann R; Sieghart W; Schnabl S; Araghi M; Hilgarth M; Reiter M; Demirtas D; Valent P; Zielinski C; Jäger U; Shehata M
Front Pharmacol; 2017; 8():319. PubMed ID: 28736522
[TBL] [Abstract][Full Text] [Related]
16. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
[TBL] [Abstract][Full Text] [Related]
17. Effect of notch1,2,3 genes silicing on NF-κB signaling pathway of macrophages in patients with atherosclerosis.
Ruan ZB; Fu XL; Li W; Ye J; Wang RZ; Zhu L
Biomed Pharmacother; 2016 Dec; 84():666-673. PubMed ID: 27697639
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
[TBL] [Abstract][Full Text] [Related]
19. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Xu J; Zhou P; Wang W; Sun A; Guo F
J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells.
Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM
Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]